Red Light Ptosis Proof-of-Concept

Status Recruiting

Clinical Trial Summary

This study tests a new treatment to help with droopy eyelids (ptosis) and eye movement problems (squint) in children and young people with genetically confirmed mitochondrial conditions - using red-light. We use a torch to shine a red light through the closed eyelid for 3 minutes a day. The study will run for 18 months. We believe that this treatment could help strengthen the muscle in the eyelid to make it easier to open the eyes, and could also help some children with squint.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06292182
Study type	Interventional
Source	University College, London
Contact	Glen Jeffery, PhD
Phone	020 7608 6800
Email	g.jeffery@ucl.ac.uk
Status	Recruiting
Phase	N/A
Start date	February 8, 2024
Completion date	November 30, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03388528` - Low Residue Diet Study in Mitochondrial Disease	N/A
Completed	`NCT04378075` - A Study to Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory Epilepsy	Phase 2/Phase 3
Completed	`NCT03678740` - Diagnostic Odyssey Survey 2
Recruiting	`NCT06051448` - Promoting Resilience in Stress Management (PRISM) and Clinical-focused Narrative (CFN) Pilot in Adults With Primary Mitochondrial Disease (PMD).	Phase 1/Phase 2
Completed	`NCT02909400` - The KHENERGY Study	Phase 2
Completed	`NCT02398201` - A Study of Bezafibrate in Mitochondrial Myopathy	Phase 2
Completed	`NCT03857880` - Identification of New Candidate Genes in Patients With Mitochondrial Disease by High Resolution Chromosome Analysis on DNA Chip
Not yet recruiting	`NCT06450964` - Establishment of Reproductive Cohort and Prediction Model of Genetic Counseling for Mitochondrial Genetic Diseases
Completed	`NCT04165239` - The KHENERGYZE Study	Phase 2
Completed	`NCT02284334` - Glycemic Index in Mitochondrial Disease
Recruiting	`NCT06080568` - Human Mitochondrial Stress-driven Obesity Resistance
Recruiting	`NCT06080581` - Mitochondrial Dysfunctions Driving Insulin Resistance
Recruiting	`NCT04802707` - Deoxynucleosides Pyrimidines as Treatment for Mitochondrial Depletion Syndrome	Phase 2
Completed	`NCT04594590` - Natural History Study of SLC25A46 Mutation-related Mitochondriopathy
Completed	`NCT04580979` - Natural History Study of FDXR Mutation-related Mitochondriopathy
Withdrawn	`NCT03866954` - Trial of Erythrocyte Encapsulated Thymidine Phosphorylase In Mitochondrial Neurogastrointestinal Encephalomyopathy	Phase 2
Recruiting	`NCT04113447` - Mitochondrial Donation: An 18 Month Outcome Study.
Enrolling by invitation	`NCT04734626` - CrCest Study in Primary Mitochondrial Disease
Completed	`NCT03832218` - Executive Function Disorders and Anxio-depressive Symptomatology in Children and Adolescents With Mitochondrial Pathologies	N/A
Terminated	`NCT02473445` - A Long-term Extension of Study RP103-MITO-001 (NCT02023866) to Assess Cysteamine Bitartrate Delayed-release Capsules (RP103) in Children With Inherited Mitochondrial Disease	Phase 2